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Abstract
Having been collected for its primary purpose in patient care, Observational Health Data (OHD) can further benefit patient well-being
by sustaining the development of health informatics. However, the potential for secondary usage of OHD continues to be hampered
by the fiercely private nature of patient-related data.
Generative Adversarial Networks (GAN) have Generative Adversarial Networks (GAN) have recently emerged as a groundbreaking
approach to efficiently learn generative models that produce realistic Synthetic Data (SD). However, the application of GAN to OHD
seems to have been lagging in comparison to other fields.
We conducted a review of GAN algorithms for OHD in the published literature, and report our findings here.
1 Introduction
1.1 Background
Most Observational Health Data (OHD) is collected as Electronic Health Records (EHR) at various points
of care in a patient’s trajectory, primarily to support and enable healthcare professionals (Cowie et al. 2016). The
patient profiles found in EHR are diverse and longitudinal, composed of demographics variables, recordings of
diagnoses, conditions, procedures, prescriptions, measurements and lab test results, administrative information,
and increasingly omics (OHDSI 2020).
Having served its primary purpose, this wealth of detailed information can further benefit patient well-being by
sustaining the development lifecycle of health informatics (HI) and machine learning (ML) algorithms. How-
ever, the potential for secondary usage of OHD continues to be hampered by the fiercely private nature of
patient-related data, and the growing popular concern towards its disclosure.
Anonymization techniques are generally employed to hinder misuse of sensitive data. Most often, through a
costly and data specific sanitization process, privacy is enhanced at the detriment of data utility. Moreover, these
techniques are fallible, and never fully prevent reidentification. To address this problem, alternative methods for
sharing sensitive data have been proposed, such as privacy-preserving distributed analysis. Although promising,
these approaches come with their own limitations.
Consequently, access to OHD is restricted to professionals with the appropriate academic credentials and financial
resources, preventing its use for the rest of the health data related occupations. For example, software developers
often do not have access to the data that will be processed by the health informatics solutions they are developing.
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1.2 Synthetic data
An alternative to traditional privacy-preserving methods is to produce fully synthetic data, with methods to build
these models include knowledge-driven and data-driven modelling (Kim et al. 2017).
Knowledge-driven modelling involves a complex theory-based process to define a simulation process representing
the causal relationships of a system. The Synthea (Walonoski et al. 2017) synthetic patient generator is one such
simulation model, in which predefined states, transitions, and conditional logic produce patient trajectories. The
parameters of the Synthea model are taken from aggregate population-level statistics of disease progression and
medical knowledge. A knowledge-based approach such as Synthea depend on prior knowledge of the system, and
most importantly how much we can understand about it (Kim et al. 2017). When modelling complex systems,
simplifications and assumptions are inevitable, leading to inaccuracies. For example, relying on population-level
statistics does not produce models capable of reproducing heterogeneous health outcomes (Chen et al. 2019).
In data-driven modelling techniques, a representation of the data is inferred from a sample distribution. In
the ML field, generative models learn to represent an estimate of the multi-modal distribution, from which
synthetic samples can be drawn (Goodfellow 2016). Generative Adversarial Networks (GAN) (Goodfellow et
al. 2014) have recently emerged as a groundbreaking approach to efficiently learn generative models that produce
realistic Synthetic Data (SD) using Neural Networks (NN). GAN algorithms have rapidly found a wide range
of applications, such as data augmentation in medical imaging (Frid-Adar et al. 2018) and representation learning
in drug discovery (Kadurin et al. 2017).
The potential impacts of GAN to healthcare and science are considerable, some of which have been realized in
fields such as medical imaging (Yi, Walia, and Babyn 2019). However, the application of GAN to OHD seems
to have been lagging (Xiao, Choi, and Sun 2018). Certain characteristics of OHD could serve to explain the
relatively slow progress. Primarily, algorithms developed for images and text in other fields were easily repurposed
for medical equivalents. However, OHD presents unique complexity in terms of multi-modality, heterogeneity
and fragmentation (Xiao, Choi, and Sun 2018). In addition to this, evaluating the realism of synthetic OHD is
intuitively complex, a problem that still burdens GAN in general. Nonetheless, interesting GAN solutions to the
challenges posed by OHD have been developed (Esteban, Hyland, and Ra¨tsch 2017; Che et al. 2017; Choi et al.
2017; Yahi et al. 2017).
2 Methods
Publications concerning OHD-GAN were identified through searches of Google Scholar and Web of Science with
the following query.
(clinical ∨ health ∨ EHR ∨ electronic health record ∨ patient) ∧ (synthetic ∨ generative adversarial ∨ GAN)
We included studies reporting the development or the application of GAN algorithms to produce OHD. Broadly,
we define the scope of OHD to be considered as low-dimensional data recorded for patient care. A more detailed
summary of the included and excluded data types can be found in Fig. 1. The excluded data types have already
been the subject of a review or would merit a review of their own. In each of the publications, we analyzed the
following aspects:
• Type of healthcare data
• GAN algorithm, learning procedure and metrics
• Intended use of the model or SD
• Evaluation metrics
• Privacy considerations
• Interpretability of the model
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Type Examples
Included
Observations Demographic information, medical classification, family history,
Timestamped observations Diagnosis, treatment and procedure codes, prescription and dosage, laboratory 
test results, physiologic measurements and intake events
Encounters Visit dates, care provider, care site
Derived Aggregated counts, calculated indicators
Excluded
Omics Genome, transcriptome, proteome, immunome, metabolome, microbiome
Imaging X-rays, computed tomography (CT), magnetic resonance imaging (MRI)
Signal Electrocardiogram (ECG), electroencephalogram (EEG)
Unstructured Narrative reports, textual
Figure 1: Types of healthcare data included and excluded from the review.
3 Results
3.1 Summary
We found a total of 23 publications describing the development or adaption of GAN algorithms for OHD. Overall,
the modelling goal is either to generate static representations of patient data, or to simulate the evolution of
patient profiles in time.
• 13 publications concerned timestamped observations (Che et al. 2017; Xiao et al. 2017; Esteban, Hyland,
and Ra¨tsch 2017; Yahi et al. 2017; Xiao et al. 2018; McDermott et al. 2018; Severo et al. 2019; Baowaly
et al. 2019; Wang, Zhang, and He 2019; Fisher, Smith, and Walsh 2019; Beaulieu-Jones et al. 2019; Cui
et al. 2019; Walsh et al. 2020).
• 10 concerned static observation and/or aggregates (Choi et al. 2017; Yoon, Jordon, and Schaar 2018; Yoon,
Jordon, and van der Schaar 2018; Camino, Hammerschmidt, and Radu State 2018; Jackson and Lussetti
2019; Baowaly et al. 2019; Yang et al. 2019; Bae et al. 2020; Zhang et al. 2020; Li et al. 2020). This
includes medGAN, the first published OHD-GAN, developed for aggregate counts of medical codes (Choi
et al. 2017).
• Among these, 5 publications evaluated the aspect of privacy, and its relation to utility (Choi et al. 2017;
Beaulieu-Jones et al. 2019; Zhang et al. 2020; Bae et al. 2020; Severo et al. 2019).
Most efforts are focused on adapting the current methods to the characteristics and complexities of OHD, of
which multimodality, heterogeneity, longitudinal irregularity, correlation complexity, missigness and noise are often
cited. While these may pose a challenge for the development of suitable GAN methods, others properties make
the prospect of success highly valuable. In fact, the most cited motivation to develop OHD-GAN is to cope with
the often limited number of samples in medical datasets and to overcome the highly restricted access to OHD.
3.2 Motivations for developing OHD-GAN
The authors cite a wide range of potential applications for generative models of OHD and the synthetic data they
produce. While some of these goals are optimistic and have yet to be realized, they paint an encouraging picture
for the value OHD-GAN. We list a few recurrent motivations here.
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3.2.1 Data augmentation
Data augmentation is mentioned in nearly all publications. Most commonly, the trained generative model or
synthetic data can improve generalization in predictive algorithms by providing additional information about the
real data distribution (Wang, Zhang, and He 2019; Che et al. 2017; Yoon, Jordon, and Schaar 2018; Yoon,
Jordon, and van der Schaar 2018). Similarly, GAN based on domain translation and semi-supervised training
approaches could support prediction tasks in healthcare that lack data with accurate labels, labeled data for rare
diseases or paired samples (Che et al. 2017; McDermott et al. 2018).
3.2.2 Enhancing privacy and increasing accessibility
SD is seen as the key to unlock the value of OHD hampered by privacy concerns. Preserving privacy can broadly
be described as reducing the risk of reidentification attacks to an acceptable level. Many studies noted that highly
restricted access to OHD is hindering machine learning, and more generally scientific progress (Beaulieu-Jones et
al. 2019; Baowaly et al. 2019; Che et al. 2017; Esteban, Hyland, and Ra¨tsch 2017; Fisher, Smith, and Walsh
2019). Due to its artificial nature, SD is proposed as a means to forgo with data use agreements, while potentially
providing greater privacy guarantee and reducing the loss of utility (Beaulieu-Jones et al. 2019; Baowaly et al.
2019; Esteban, Hyland, and Ra¨tsch 2017; Fisher, Smith, and Walsh 2019; Walsh et al. 2020). Preventing the
disclosure fo commercially sensitive information is also cited (Severo et al. 2019). Overall, enabling access to
greater variety, quality and quantity of OHD could have positive effects in a wide range of fields, such as software
development, education, and training of medical professionals.
3.2.3 Enabling precision medicine
The ability to conduct simulations of disease progression for individual patients could have transformative impacts
on healthcare. Generative models conditioned on the patient’s baseline state could help inform clinical decision
making, such as predicting patient-specific response to drugs, a problem known as Individualized Treatment Effects
(ITE) (Yahi et al. 2017; Walsh et al. 2020). Additionally, stochastic simulations of individual patient profiles
could help quantify risk at an unprecedented level of granularity (Fisher, Smith, and Walsh 2019).
3.2.4 Patient and disease models
Realistic synthetic data implies a model that approximates the process that generated the real information (Es-
teban, Hyland, and Ra¨tsch 2017). Achieving models of significant complexity would open up new simulation
possibilities for developing predictive systems and methods. In clinical research, such models could help quantify
cause and effect, simulate different study designs, provide control samples or more generally give us a better
understanding of disease progression in relation to initial conditions (Fisher, Smith, and Walsh 2019; Yahi et al.
2017; Walsh et al. 2020).
3.3 OHD feature engineering
Few publications made use of OHD in its initial form. In most cases, feature engineering was used to adapt the
data to the scientific question, or to make it intelligible for particular algorithms. The data is transformed into
one of four modalities: time series, point-processes, ordered sequences or aggregates.
3.3.1 Regular time-series
OHD is sometimes generated in a somewhat regular fashion, at fixed time intervals. This is the case for automatic
measurements performed by bedside monitors, for example. However, in most cases data are sporadic, with many
missing observations across time and dimensions. Generally, transformations such as data imputation (Yahi et
al. 2017) data imputation coupled with training (Fisher, Smith, and Walsh 2019; Walsh et al. 2020), binning
into fixed-size time intervals (Esteban, Hyland, and Ra¨tsch 2017; Che et al. 2017; McDermott et al. 2018) or
a combination of binning and imputation (Wang, Zhang, and He 2019) are employed to preprocess the data.
Binning is however undesirable, leading to some degree of loss of information (Lipton, Kale, and Wetzel 2016).
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3.3.2 Point-processes
In some cases, it is of interest to model the time intervals between events, such as hospital visits for a particular
patient. To obtain temporal point-processes, time-series of a single concept are transformed into the time deltas
between consecutive occurrences (Xiao et al. 2017; Xiao et al. 2018).
3.3.3 Ordered sequences
For input into predictive models, patients trajectories are sometimes represented as variable-length, ordered vectors
of medical events. By borrowing methods developed for sentences in Natural Language Processing, medical events
in a patient’s journey are projected into a trained embedding (Che et al. 2017; Cui et al. 2019).
3.3.4 Aggregates
For the same purpose as ordered sequences, a patient’s medical history is often aggregated into a fixed-sized
vector representations (Choi et al. 2017; Camino, Hammerschmidt, and Radu State 2018; Baowaly et al. 2019;
Zhang et al. 2020). Each dimension is then the count or binary occurence of a particular medical concept.
Demographic variables, indicators and dates are also concatenated to theses representations (Yoon, Jordon, and
Schaar 2018; Yoon, Jordon, and van der Schaar 2018).
3.4 Modelling approaches
The modelling approaches, neural network algorithms and learning strategies employed to develop OHD-GAN
cannot be succinctly generalized. In addition to being dependent on the data representation, these are chosen
according to the generation task and the intended use of the model and synthetic data. Nonetheless, we present
here a few of the main techniques. A list of the datasets reported in the publications is presented in Section 5.
3.4.1 Model architecture and learning
For time-series data, Recurrent Neural Networks (RNN) are most often employed (Xiao et al. 2017), including
the Long Short-Term Memory (LSTM) subclass (Esteban, Hyland, and Ra¨tsch 2017; Xiao et al. 2018; Wang,
Zhang, and He 2019). A notable exception is presented by Fisher et al., followed by Walsh et al. who make use
of a Restricted Boltzmann Machine (RBM), arguing that a number of their properties make them desirable
for the purpose of simulating patient trajectories (Fisher, Smith, and Walsh 2019; Walsh et al. 2020). More
specifically, Latent Variable Conditional RBM is applied to longitudinal time-series, conditioned on initial
static features and patient state. The authors show that RBM allows for missing features to be imputed on the
fly from the conditional distribution. Furthermore, they argue that the probabilistic nature of RBM captures the
stochasticity of disease evolution.
To deal with the incompatibility of ordinal and categorical features with backpropagation, in the algo-
rithm medGAN Choi et al. pre-train an Autoencoder (AE) to project the samples to, and from, a continuous
latent space representation (Choi et al. 2017). The trained decoder portion of the AE then maps the latent-
space representation of the generator back to discrete features. To improve on medGAN, Camino et al. trial
multiple GAN methods for categorical features, such as Wassertein GAN with gradient penalty (WGAN-GP)
with a softmax output, Gumbel-Softmax GAN, and modify the decoder in ARAE and medGAN by adding
a Gumbel-Softmax output (Camino, Hammerschmidt, and Radu State 2018). They find that the proposed
alternative gives better results in general, but that the choice of a model will depend on data characteristics,
of which sparsity seems to have the biggest influence. The WGAN-GP is also trialed by Baowaly et al. along
with boundary-seeking GAN (BGAN), respectively termed medWGAN and medBGAN, in an effort to pro-
duce more realistic samples, with meaningful success, particularly with medBGAN (Baowaly et al. 2019).
With EMR Wasserstein GAN (EMR-WGAN), Zhang et al. remove the AE and introduce two normalization
techniques to stabilise training (Zhang et al. 2020).
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An example of domain translation, Yoon et al. employe a cycle-consistent conditional WGAN to translate het-
erogeneous patient information from one hospital to another, correcting feature and distribution mismatch (Yoon,
Jordon, and Schaar 2018). Encoder-decoder pairs, one for each hospital dataset, are trained to map records to
and from a shared latent representation. In a similar approach, McDermott et al. demonstrate a semi-supervised
approach with Cycle WGAN to leverage the large amounts of unpaired pre/post-treatment time-series in ICU
data (McDermott et al. 2018).
For ordered sequences of medical codes, Che et al. use a encoder decoder Convolutional Neural Network
(CNN) with Variational Contrastive Divergence (VCD) to produce neighbouring records of an input patient
(Che et al. 2017). The ehrGAN generator is trained decode a random vector mixed with the latent space
representation of a particular patient. In a form of semi-supervised learning, the trained ehrGAN model is then
incorporated into the loss function of a predictor where it can provide additional information about each input
record by producing neighbors. One dimensional CNN are also used for time-series (Severo et al. 2019).
3.4.2 Conditional models
Auxiliary information can guide the generative process and generally improve performance on multimodal data.
Conditional models also enable generating data of a desired class, conditioned on a demographic profile (Fisher,
Smith, and Walsh 2019) or various other static patient features (Esteban, Hyland, and Ra¨tsch 2017). This
information is given as additional input to the generator and discriminator, or concatenated with dynamic features
at each time-step for sequential data. Often, capturing the inter-dimensional correlations in time series will lead to
increased performance. Wang et al. demonstrate an interesting sequential variation on this idea to generate time
series of patient state and medication dosage. In their algorithm, patient state at the current timestep informs the
concurrent medication dosage, which in turn affects the patient state in the upcoming timestep (Wang, Zhang,
and He 2019). Zhang et al. show that conditional training with categorical labels for the samples improves utility
for small samples, but not with larger samples (Zhang et al. 2020). In a particular case where the class imbalance
ratio is itself the sensitive information, Severo et al. generate a synthetic dataset with equal number of samples
for each class (Severo et al. 2019).
For the task of estimating Individualized Treatment Effects (ITE), the problem is often that counterfactual
outcomes are never observed or that treatment selection is highly biased (Yoon, Jordon, and van der Schaar
2018; McDermott et al. 2018; Walsh et al. 2020). To overcome this, Yoon et al. employ a pair of GAN,
one for counterfactual imputation and another for ITE estimation, to capture the uncertainty in the unobserved
counterfactual treatment outcomes and provide confidence intervals. Similarly, the concept of “digital twins” is
introduced by Walsh et al. who generate placebo control twins of patients in the active trial arm, from their
baseline state.
3.5 Validating the model and verifying the synthetic data
To asses the solution to a generative modelling problem, it is necessary to validate the model obtained, and
subsequently to verify its output. GANs aim to approximate a data distribution P , using a parameterized model
distribution Q (Borji 2018). Thus, in evaluating the model, the goal is to validate that the learning process has
led to a sufficient approximation. Approaches to achieve this are either quantitative or qualitative.
3.5.1 Qualitative evaluation
The qualitative evaluation approaches are mainly preference judgement or discrimination tasks (Borji 2018). In
these tasks, participants, such as medical professionals, are asked to rank the quality of real and synthetic samples,
or to discriminate between each (Choi et al. 2017; Beaulieu-Jones et al. 2019). Similarly, visual inspection of
statistics or projections of the data can help get a better understanding of model behaviour (Beaulieu-Jones et
al. 2019; Che et al. 2017).
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3.5.2 Quantitative evaluation by comparing distributions
Numerous metrics have been proposed to compare the distributions of real and synthetic data (Borji 2018).
The Maximum Mean Discrepancy (MMD) metric checks the dissimilarity between two probability distributions
using samples drawn independently from each. With this metric, Esteban et al. compare distributions of time
series by defining a radial basis function (RBF) kernel (Esteban, Hyland, and Ra¨tsch 2017). The 2-sample test
(2-ST) answers weather two samples originate from the same distribution through the use of a statistical test. For
example, the kolmogorov-smirnov statistical test is used on aggregate count data by Baowaly et al. and on time
series data by Fisher et al. (Fisher, Smith, and Walsh 2019; Baowaly et al. 2019). As an alternative, a classifier
can be trained to discriminate real from synthetic units (Fisher, Smith, and Walsh 2019; Walsh et al. 2020).
In a similar approaches, Xiao et al. compare the distributions based on a domain specific measure and Zhang et
al. compared the distribution of the samples in latent space according to the mean of the variance (Xiao et al.
2017; Zhang et al. 2020) .
3.5.3 Quantitative evaluation of utility
Another way to assess the ability of the model replicate the distribution of the real data is to compare the in-
formation content of both samples. In other words, a utility metric measures the value of the work that can be
done with the synthetic data. Simplistic measures of utility include comparing real and synthetic dimensional
distributions (Beaulieu-Jones et al. 2019; Choi et al. 2017; Baowaly et al. 2019) interdimensional correla-
tions (Beaulieu-Jones et al. 2019), first-order proximity (Zhang et al. 2020) or time-lagged correlations and
covariates (Fisher, Smith, and Walsh 2019; Walsh et al. 2020).
A more convincing measure of utility is to evaluate the performance of discriminative models trained on the
learned features of the model or the synthetic data (Borji 2018), this is usually done in comparison with baselines.
Examples include dimension-wise prediction (Choi et al. 2017; Camino, Hammerschmidt, and Radu State 2018;
Baowaly et al. 2019), association rule mining (Baowaly et al. 2019), predictor accuracy (Bae et al. 2020) or testing
the performance on real data of a predictor trained on synthetic data (Esteban, Hyland, and Ra¨tsch 2017). Models
trained to make forward predictions from past observations can simply be evaluated for accuracy (Xiao et al. 2018;
McDermott et al. 2018).
To evaluate the robustness of the algorithm to data characteristic, synthetic training data with known properties
is often employed to assess their effect on model performance (Yoon, Jordon, and van der Schaar 2018; Camino,
Hammerschmidt, and Radu State 2018; Esteban, Hyland, and Ra¨tsch 2017).
3.5.4 Utility gain
The representation learned by the model can compensate for lack of diversity in a real sample and lead to improved
performance in predictive models. Examples include generating unobserved counterfactual outcomes (Yoon,
Jordon, and van der Schaar 2018), or generating neighboring samples to help generalization in predictors (Che et
al. 2017).
In another approach capturing the ability of generative models to produce statistically meaningful samples, (Fisher,
Smith, and Walsh 2019) simulate individualized patient trajectories to quantify the influence of starting conditions
on disease progression.
3.6 Privacy
To evaluate the risk of reidentification on synthetic data, Choi et al. and Zhang et al. conduct empirical analysis
according to the definitions of Presence Disclosure, Attribute Disclosure (Choi et al. 2017) and Reproduction
rate (Zhang et al. 2020). Both studies report low success rate for these types of attacks, while little effect from
the sample size.
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It seems intuitively possible that the artificial nature of synthetic data essentially prevents associations with real
patients, however the question is never directly addressed in the publications. Rather, attempts are made to
confer traditional privacy guarantees through differentially-private stochastic gradient descent (Beaulieu-Jones et
al. 2019; Esteban, Hyland, and Ra¨tsch 2017) or with a probabilistic scheme that ensures indistinguishability (Bae
et al. 2020). Interestingly, Bae et al. also employ a trained discriminative model in the loss function of the
generator to ensure utility is preserved. Interestingly, preventing overfitting and preserving privacy may not be
conflicting goals (Wu et al. 2019; Mukherjee et al. 2019).
4 Discussion
4.1 Analysis of OHD-GAN
Overall, a number of recurrent factors influenced the outcome of OHD-GAN development and synthetic data
generation tasks. The multimodality and heterogeneity of OHD can make training a model challenging, particularly
more so when the learning task is poorly defined or the scope of the problem is too large. Moreover, the complexity
of health-related data makes the assessment of synthetic data ambiguous, thus demanding stronger evidence to
claims.
4.1.1 Scope and evaluation mismatch
A number of publications suffer from attempting to produce representations of patients that are aggregated, highly
information dense or multidimensional while providing a simplistic assessment of their realism. These metrics are
often high-level and generally applicable.
For medical experts, these representations are meaningless. As such, the results of qualitative evaluation often
state that synthetic data is indistinguishable from the real data (Choi et al. 2017; Wang, Zhang, and He 2019).
It is doubtful that they could in fact be.
Reproducing aggregate statistical properties is rather unconvincing evidence that a model has learned to reproduce
the complexity of biological systems. For example, Choi et al. find that although the synthetic sample seemed
statistically sound, it contained gross errors such as gender code mismatches and suggest the use of domain-
specific heuristics (Choi et al. 2017). They may be contradictory, such as when the ranking condition frequencies
are wrong, but the data augmentation leads to improved performance (Che et al. 2017). In addition, competing
methods are often compared with different metrics or with contradictory results in different datasets (Camino,
Hammerschmidt, and Radu State 2018; Choi et al. 2017; Baowaly et al. 2019; Zhang et al. 2020).
Utility-based metrics provide a more solid evaluation of data quality. However, these metrics only confirm the
value of the data according to a narrow context. They are indicative of realism so far as a patient’s state is
indicative of a medical outcome. Moreover, they do not provide any insight about the validity of the relations
found in a patient record and its overall consistency.
4.1.2 Altered and misrepresented data
Overall, the approaches to OHD-GAN concern highly engineered representations of patient records. The complex
relationships found in medical data often cannot be represented in the simplistic one-hot encodings used for
aggregate counts and valuable information is lost when forcing time-series into a regular representation. Generally,
the data is engineered to accommodate existing algorithms.
Deep architectures are based on concept multiple layers of non-linear functions are needed to learn complicated
high-level abstractions (Bengio 2009). In fact, hierarchical representations of EHR that capture the sequential
order of visits and co-occurrence of codes in a visit have led to improved predictor performance, and also allowed for
meaningful interpretation of the model (Choi et al. 2016). Similarly, models of time-series based on a continuous
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time representation, such as found in EHR data, have shown improved accuracy over discrete time-representations
(Rubanova, Chen, and Duvenaud 2019; De Brouwer et al. 2019).
4.2 Recommendations
4.2.1 Basic models
Modelling efforts for OHD-GAN should be limited in scope to a single data type or modality. This is favourable
for a number of evaluation related aspects. Firstly, it makes qualitative evaluation by visual inspection from
experts possible and meaningful. Secondly, in relation to the first point, the behaviour of the model can be assed
straightforwardly. This means the generative process can be influenced intentionally to observe the effect on the
properties of the output. Finally, it allows for quantitative evaluation with domain specific metrics.
4.2.2 Data-driven architecture
The algorithm architecture of OHD-GAN should be engineered to match the process that generated the data, not
the other way around. Data should be used and generated in the form it is first collected. In addition to preventing
information loss, this ensures models will reflect the generative process that produced the real data. Such models
are more likely to provide insights into the system they are taught to imitate and further our understanding about
them. Furthermore, the learned statistical distribution is inevitably more meaningful and interpretable, facilitating
applications in the healthcare domain and supporting results inferred from it.
4.3 Directions for futures research
4.3.1 Building a patient model
The ultimate goal for generative models of OHD must be an all encompassing patient model capable of generating
full EHR records on demand. This is in fact the intention of the patient simulator Synthea. Once basic models
of health data, as described in Section 4.2.1, have been developed and validated, these can be progressively
combined in a modular fashion to obtain increasingly complex patient simulators. Furthermore, having designed
the architecture of these basic models on the underlying data in a way that is comprehensible, as described in
Section 4.2.2, will facilitate the composition of more complex models. Inputs, outputs and parts of these models
can be conditionally attached to others such that the generative process occurs in a way that reflects the real
generative process.
4.3.2 Evaluating complex patient models
Once more complex models are developed, the problem is again finding meaningful evaluation metrics of data
realism. In their publication exploring the validation of the data produced by Synthea, Chen et al. provide an
interesting idea to achieve this (Chen et al. 2019). Noting that the quality of care is the prime objective of
a functional healthcare system, they suggest using Clinical quality measures (CQM) to evaluate the synthetic
data. These measures “are evidence-based metrics to quantify the processes and outcomes of healthcare”, such
as “the level of effectiveness, safety and timeliness of the services that a healthcare provider or organization
offers.”(Chen et al. 2019). High-level indicators such as CQMs domain specific measures of quality, specifically
designed for higher level or multimodal representations of healthcare data. At the individual level, Walsh et al.
employ domain specific indicators of disease progression and worsening and compare agreement of the simulated
patient trajectories with the factual timelines (Walsh et al. 2020).
In addition to CQM, we propose the use of the Care maps used by the Synthea model to simulate patient
trajectories as evaluation metrics (Walonoski et al. 2017). Care maps are transition graphs developed from
clinician input and Clinical Practice Guidelines, of which the transition probabilities are gathered from health
incidence statistics. While these allow the Synthea algorithm to simulate patient profile with realistic structure,
they also prevent it from reproducing real-world variability. Conversely, while GAN have the ability to reproduce
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the quirks of real data, they also lack the constraints preventing nonsensical outputs. As such, Care maps provide
an ideal metric to check if the synthetic data conforms to medical processes.
5 Datasets
Coalition Against Major diseases Online data Repository for AD (Neville et al. 2015)
• Longitudinal trajectories of 44 categorical, ordinal and continuous features.
• 1909 patients.
• 18 months, at 3 month intervals.
New York Presbyterian/Columbia University Irving Medical Center (Hripcsak et al. 2015)
• Observations such as prescriptions laboratory tests.
• 485,306 patients.
• Between 2000 and 2103.
Philips eICU (Pollard et al. 2018)
• Around 200,000 patients.
• From 208 care units across the US.
• Collected through the critical care telehealth program.
Multiparameter Intelligent Monitoring in Intensive Care (MIMIC-III v1.4) (Johnson et al. 2016)
• 474 million patient-centric state observations in intensive care units (ICUs).
• 43,000 patients.
• Between 2001 and 2012.
Vanderbilt University Medical Center Synthetic Derivative (“Synthetic Derivative — Department of
Biomedical Informatics”)
• De-identified warehouse of over 2.2 million EHR
Wisconsin data from the UCI machine learning repository (Dua and Graff 2019)
• Breast cancer, chronic kidney disease, heart disease, and prostate cancer datasets, with 30, 24, 13, and 8
features, respectively.
Ward2ICU (Severo et al. 2019)
• Electronic Health Records of patients from Hospital Mater Dei, a tertiary hospital, located in Belo Horizonte,
Brazil
• Adult patients with an average age of 40, between the years of 2014 and 2019
• 25 vitals, of which 5 currently available, 20 samples per patient
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